Klinefelter syndrome and sex chromosome aneuploidy

A tall, shy fourteen-year-old boy is referred by his school counsellor because he is struggling academically, socially withdrawn, and has not started puberty while his peers have. On examination his testicular volume is 4 mL bilaterally — small and firm — and he has mild gynaecomastia. The same boy may have been flagged years earlier by his speech pathologist for a language disorder, or he may present only in his thirties at a fertility clinic with azoospermia. The fellowship task is to recognise that this is a sex chromosome aneuploidy — the commonest chromosomal disorder in humans — and to lay out a surveillance and management framework that follows the person through childhood, adolescence, and adulthood. ^{[1] [2]}

Overview & Definition

Sex chromosome aneuploidies are chromosomal disorders caused by the presence of one or more additional sex chromosomes — or, in the case of Turner syndrome, the absence of one — and they are distinguished from autosomal aneuploidies by a paradox: they are the commonest chromosomal disorders in humans, yet the mildest in phenotype. Klinefelter syndrome, the prototypical and commonest form, is the phenotype produced by a 47,XXY karyotype: one or more extra X chromosomes in a male. It was first described by Harry Klinefelter in 1942 as a syndrome of small testes, gynaecomastia, and azoospermia, and the chromosomal basis was established by Jacobs and Strong in 1959, making it the first human chromosomal disorder to be mapped to a specific karyotype. ^{[2] [1]}

The clinical challenge of sex chromosome aneuploidies is that the phenotype is mild, variable, and overlaps with the general population. A boy with 47,XXY may have language delay, tall stature, and learning difficulties — features shared with many children in any classroom — and the diagnosis is easily missed. An estimated fifty to seventy-five per cent of males with Klinefelter syndrome are never diagnosed in life, and the diagnosis rate for 47,XXX and 47,XYY is even lower, because those phenotypes are subtler still. This is the fundamental teaching point: sex chromosome aneuploidies are common but invisible, and the clinician's task is to recognise the pattern across the lifespan rather than to wait for a neonatal diagnosis that, for most, never comes. ^{[1] [5]}

The distinction between sex chromosome aneuploidies and autosomal trisomies is mechanistic and phenotypic. An extra chromosome 21 — as in Down syndrome — produces a severe, recognisable, multisystem phenotype because the gene dosage of an entire autosome is disrupted. An extra sex chromosome produces a milder phenotype because of the X-inactivation mechanism: the additional X is largely inactivated, and the residual effect comes from escape genes — genes that evade inactivation and are therefore overexpressed — and from the overall dosage of XIST RNA and the subtle disruption of the inactivation machinery. The Y chromosome, by contrast, carries few genes, and its presence in 47,XYY adds mainly the SRY effect and the neuroanatomical contribution of Y-linked gene expression. ^{[3] [6]}

References10ShowHide

1. [1]Groth KA, Skakkebæk A, Høst C, Gravholt CH, Bojesen A. Clinical review: Klinefelter syndrome--a clinical update. J Clin Endocrinol Metab, 2013.PMID 23118429
2. [2]Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E. Klinefelter's syndrome. Lancet, 2004.PMID 15262106
3. [3]Kanakis GA, Nieschlag E. Klinefelter syndrome: more than hypogonadism. Metabolism, 2018.PMID 29382506
4. [4]Gies I, Unuane D, Velkeniers B, De Schepper J. Management of Klinefelter syndrome during transition. Eur J Endocrinol, 2014.PMID 24801585
5. [5]Tartaglia N, Howell S, Davis S, et al. Early neurodevelopmental and medical profile in children with sex chromosome trisomies: Background for the prospective eXtraordinarY babies study to identify early risk factors and targets for intervention. Am J Med Genet C Semin Med Genet, 2020.PMID 32506668
6. [6]Ross JL, Zeger MP, Kushner H, et al. An extra X or Y chromosome: contrasting the cognitive and motor phenotypes in childhood in boys with 47,XYY syndrome or 47,XXY Klinefelter syndrome. Dev Disabil Res Rev, 2009.PMID 20014371
7. [7]Wigby K, D'Epagnier C, Howell S, et al. Expanding the phenotype of Triple X syndrome: A comparison of prenatal versus postnatal diagnosis. Am J Med Genet A, 2016.PMID 27644018
8. [8]Howell S, Buchanan C, Davis SM, et al. Eosinophilic esophagitis in individuals with sex chromosome aneuploidies: Clinical presentations and management implications. Mol Genet Genomic Med, 2021.PMID 34738344
9. [9]Davis SM, Howell S, Janusz J, et al. Testosterone Effects on Short-term Physical, Hormonal, and Neurodevelopmental Outcomes (TESTO) in Infants With 47,XXY. J Clin Endocrinol Metab, 2025.PMID 40177735
10. [10]Gravholt CH, Andersen NH, Christin-Maitre S, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome. Eur J Endocrinol, 2024.PMID 38748847